Login / Signup

Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients.

Zesheng AnXian ZhouYanfeng LiJane JaquithKathleen McCarthy-FruinJennifer SlettenKenneth J WarringtonCornelia WeyandCynthia S CrowsonSaranya ChumsriKeith L KnutsonGabriel Figueroa-ParraAlain Sanchez-RodriguezUma ThanarajasingamAlí Duarte-GarcíaHu Zeng
Published in: medRxiv : the preprint server for health sciences (2023)
Patients with rheumatic diseases mount robust humoral immunity towards 3 doses of COVID-19 mRNA vaccines.Disease activity and biomarkers remain stable following 3 doses of COVID-19 mRNA vaccines.
Keyphrases